Bronchial artery infusion of antineoplastic agents
Takeuchi, A.
Nihon Rinsho. Japanese Journal of Clinical Medicine 38(7): 2683-2690
1980
ISSN/ISBN: 0047-1852 PMID: 6257949 Document Number: 154996
Document emailed within 1 workday
Related Documents
Nishiya, I.; Yoshizumi, N. 1985: New therapy of cervical cancer--direct infusion of antineoplastic agents into the uterine artery Nursing Technique 31(13): 1814-1816Yiengpruksawan, A.; Watanabe, G.; Ono, Y.; Tsurumaru, M.; Akiyama, H. 1984: Tracheoesophageal fistula as a result of bronchial artery infusion therapy International Surgery 69(4): 351-355
Matsumura, K.; Sawada, K.; Ishida, I.; Seki, Y.; Fukuma, S.; Kuwabara, T.; Maruyama, T. 1985: The clinicopathological effects of infusion of cis-platinum into the bronchial artery on lung cancer Gan no Rinsho. Japan Journal of Cancer Clinics 31(3): 240-245
Tokutome, A.; Taniguchi, R.; Maeda, K.; Saito, Y.; Ishii, T.; Minami, S.; Wano, Y.; Ota, T.; Saitoh, H.; Takeda, K. 2018: The Usefulness of a Pamphlet for Preventing Exposure to Antineoplastic Agents at Cancer Patients' Homes and an Awareness Survey for Pharmacists about Providing Information to Cancer Patients about Exposure to Antineoplastic Agents Gan to Kagaku Ryoho. Cancer and ChemoTherapy 45(5): 833-839
Pang, Q.Q. 1989: Results of bronchial artery chemotherapy infusion in lung cancer--report of 82 cases Zhonghua Zhong Liu Za Zhi 11(1): 60-63
Komatsu, H.; Kawamura, M.; Satou, K.; Yoneda, R. 1986: A chemotherapy regimen including CDDP in patients with bronchogenic carcinoma--a comparison between bronchial artery infusion and intravenous administration Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(11): 3175-3179
Breukels, O.; van der Gronde, T.; Simons-Sanders, K.; Crul, M. 2018: Antineoplastic Drug Contamination on the Outside of Prepared Infusion Bags International Journal of Pharmaceutical Compounding 22(4): 345-349
Tanneberger, S. 1985: Antineoplastic chemotherapy for bronchial carcinoma Archiv für Geschwulstforschung 55(1): 63-71
1971: Chemistry of antineoplastic agents Minerva Medica 62(28): 1492
Mitolo-chieppa, D.; Ceci, A. 1974: Neurotoxicity of some antineoplastic agents Bollettino della Societa Italiana di Biologia Sperimentale 50(17): 1333-1359
Aiello, E.; Dattolo, G.; Cirrincione, G.; Almerico, A.M.; Diana, P.; Grimaudo, S.; Mingoia, F.; Barraja, P. 1995: Azolophenanthridines as antineoplastic agents Farmaco 50(6): 365-368
Shigeoka, Y.; Shimizu, E. 2007: Myelosuppression due to antineoplastic agents Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 8): 287-293
Wada, T.; Matsui, H. 2013: Research development of novel antineoplastic agents Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 142(4): 149
Pettit, G.R.; Srirangam, J.K.; Barkoczy, J.; Williams, M.D.; Boyd, M.R.; Hamel, E.; Pettit, R.K.; Hogan, F.; Bai, R.; Chapuis, J.C.; McAllister, S.C.; Schmidt, J.M. 1998: Antineoplastic agents 365. Dolastatin 10 SAR probes Anti-Cancer Drug Design 13(4): 243-277
Berti, T. 1970: Specific histotropism of antineoplastic agents La Clinica Terapeutica 55(4): 293-303
Orfi, L.; Wáczek, F.; Szabó, M.; Kövesdi, I.; Mészáros, G.; Idei, M.; Horváth, A.; Hollósy, F.; Mák, M.; Szegedi, Z.; Szende, B.; Kéri, G.; Noszál, B. 1999: Preparation and characterization of potential antineoplastic agents Acta Pharmaceutica Hungarica 69(3): 115-122
Schmoll, H.J.; Hiddemann, W.; Rustum, Y.; Köhne-Wömpner, C.H. 1992: The emerging role for biomodulation of antineoplastic agents Seminars in Oncology 19(2 Suppl 3: 1-3
Le Guern, M. 1987: DNA-topoisomerase II: Cellular targets of antineoplastic agents Pathologie-Biologie 35(4): 343-345
Matsumura, Y. 1982: Intravesical instillation of adriamycin and other antineoplastic agents Gan to Kagaku Ryoho. Cancer and ChemoTherapy 9(3): 372-376
Sakurai, Y. 1975: Deveolpment of new antineoplastic agents and their clinical characteristics Nihon Rinsho. Japanese Journal of Clinical Medicine 33(5): 1892-1896